![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjPSn44KMPX-a-tSaFulV7SF7csdwfiXpp1nDWOfuDN16yLWczWuHVz3xDlaafBziFuAxgiKxdFUk2qlo4fE55DaW85v1NSTG5mZjRGFtoDARZ-Z12ilsFi_znZtDF96exD4WQGV5j-D7c/s320/positrones.bmp)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEik3n3Zk-Ax5gcz68i9jMh_6Wyns6lecW4vz3PnZDcnrVs4cNlHHa_oXJHc7_MDLwSSeUWagnLGMpgyWhENYr2YAyYvsNY26HgttE2D6_G0S50oKyNthyU8SQIisEXCA_zOjnD4NeWvb-0/s320/ahrq_banner.gif)
Positron Emission Tomography for Nine Cancers(Bladder, Brain, Cervical, Kidney, Ovarian, Pancreatic, Prostate, Small Cell Lung, Testicular)
Issue
Positron emission tomography (PET) is a form of nuclear medicine imaging that detects and establishes metabolic abnormalities in tissue. A PET scanner produces an image of the area of interest through the detection of radiation emitted from a positron-emitting radionuclide that is introduced into the patient and that accumulates in the target tissue.
Technology Assessment
Download Technology Assessment [PDF, 2MB]
abrir aquí para poder acceder al documento PDF 2MB:
Centers for Medicare & Medicaid Services
No hay comentarios:
Publicar un comentario